University of Oxford - Pharmaco- and Device Epidemiology, University of Oxford - Pharmaco- and Device Epidemiology, University of Oxford - Pharmaco- and Device Epidemiology, Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC), IQVIA - Real World Solutions, University of Oxford - Rheumatology and Musculoskeletal Sciences, Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC), IQVIA - Real World Solutions, University of Bordeaux - CHU de Bordeaux, University of Tartu - Institute of Computer Science, University of Oxford - Pharmaco- and Device Epidemiology, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), University of Tartu, IQVIA - Real World Solutions, Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC), IQVIA - Real World Solutions, University of Oxford - Pharmaco- and Device Epidemiology, University of Oxford - Rheumatology and Musculoskeletal Sciences, University of Oxford - Pharmaco- and Device Epidemiology and University of Oxford - Pharmaco- and Device Epidemiology

INRIA Paris, Assistance Publique-Hopitaux de Paris (AP-HP) - Hôpital Européen Georges Pompidou, University of Bordeaux - CHU de Bordeaux, University of Bordeaux - CHU de Bordeaux, University of Bordeaux - CHU de Bordeaux, Université Paris Est Créteil (UPEC) - IMRB, INRIA Paris, Assistance Publique-Hopitaux de Paris (AP-HP) - Hôpital Européen Georges Pompidou, Assistance Publique-Hopitaux de Paris (AP-HP) - Hôpital Européen Georges Pompidou, Bordeaux University Hospital - CHU Bordeaux and INRIA Paris

University of Bordeaux - SISTM team, UMR 1219, University of Bordeaux - CHU de Bordeaux, University of Bordeaux - CHU de Bordeaux, University of Bordeaux - ISPED, INSERM U1219, Inria BSO, University of Bordeaux - SISTM team, UMR 1219 and Independent